514 related articles for article (PubMed ID: 16038162)
21. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM
Value Health; 2011; 14(5):732-9. PubMed ID: 21839412
[TBL] [Abstract][Full Text] [Related]
22. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
[TBL] [Abstract][Full Text] [Related]
23. EQ-5D-5L norms for the urban Chinese population in China.
Yang Z; Busschbach J; Liu G; Luo N
Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
[TBL] [Abstract][Full Text] [Related]
24. Italian population-based values of EQ-5D health states.
Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
[TBL] [Abstract][Full Text] [Related]
25. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
26. Valuation of the EQ-5D-3L in Russia.
Omelyanovskiy V; Musina N; Ratushnyak S; Bezdenezhnykh T; Fediaeva V; Roudijk B; Purba FD
Qual Life Res; 2021 Jul; 30(7):1997-2007. PubMed ID: 33713323
[TBL] [Abstract][Full Text] [Related]
27. The impact of differences between patient and general population EQ-5D-3L values on the mean tariff scores of different patient groups.
Little MH; Reitmeir P; Peters A; Leidl R
Value Health; 2014 Jun; 17(4):364-71. PubMed ID: 24968996
[TBL] [Abstract][Full Text] [Related]
28. Valuations of EQ-5D health states: are the United States and United Kingdom different?
Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
[TBL] [Abstract][Full Text] [Related]
29. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
[TBL] [Abstract][Full Text] [Related]
30. Capturing Valuation Study Sampling Uncertainty in the Estimation of Health State Utility Values Using the EQ-5D-3L.
Poulimenos S; Round J; Baio G
Med Decis Making; 2024 May; 44(4):393-404. PubMed ID: 38584481
[TBL] [Abstract][Full Text] [Related]
31. The social tariff of EQ-5D is not adequate to assess quality of life in patients with low back pain.
Zamora J; Kovacs F; Abraira V; Fernández C; Lázaro P;
Qual Life Res; 2007 Apr; 16(3):523-31. PubMed ID: 17111230
[TBL] [Abstract][Full Text] [Related]
32. Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L.
Karim S; Craig BM; Groothuis-Oudshoorn CGM
Health Qual Life Outcomes; 2022 May; 20(1):85. PubMed ID: 35614472
[TBL] [Abstract][Full Text] [Related]
33. A Value Set for the EQ-5D-Y-3L in the Netherlands.
Roudijk B; Sajjad A; Essers B; Lipman S; Stalmeier P; Finch AP
Pharmacoeconomics; 2022 Dec; 40(Suppl 2):193-203. PubMed ID: 36216977
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
35. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
[TBL] [Abstract][Full Text] [Related]
36. A comparison of individual and social time trade-off values for health states in the general population.
Burström K; Johannesson M; Diderichsen F
Health Policy; 2006 May; 76(3):359-70. PubMed ID: 16214258
[TBL] [Abstract][Full Text] [Related]
37. Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Scuffham PA
Health Qual Life Outcomes; 2013 Sep; 11():149. PubMed ID: 24070162
[TBL] [Abstract][Full Text] [Related]
38. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
[TBL] [Abstract][Full Text] [Related]
39. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
Rand-Hendriksen K; Augestad LA
Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
[TBL] [Abstract][Full Text] [Related]
40. A comparison of injured patient and general population valuations of EQ-5D health states for New Zealand.
Wilson R; Hansen P; Langley J; Derrett S
Health Qual Life Outcomes; 2014 Feb; 12():21. PubMed ID: 24548314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
